相关实验视频

Updated: May 20, 2025

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

377

在一个患者中,通过塞马格卢提德实现超过30%的体重减轻:一个案例报告

Sidra Danish1, Vallabh Dogra1, Uzma Rauf1

  • 1Internal Medicine, Bon Secours Mercy Health, Toledo, USA.

Cureus
|March 24, 2025
PubMed
概括

在一个患有病态肥胖症的患者中,塞马格卢提德治疗导致了超过30%的显著体重减轻. 这种药物还解决了高血压和正常化葡萄糖水平,展示了其广泛的益处.

关键词:
这种高血压,高血压.高血压和治疗治疗.糖尿病前期的治疗方法塞马格卢提德 (semaglutide) 是一种可怕的药物.减肥 减肥 减肥 减肥 减肥 减肥

更多相关视频

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution

Published on: April 16, 2019

11.8K
A Murine Model of Vertical Sleeve Gastrectomy06:47

A Murine Model of Vertical Sleeve Gastrectomy

Published on: December 18, 2017

11.1K

相关概念视频

Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
146